AU2001219672A1 - Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections - Google Patents

Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections

Info

Publication number
AU2001219672A1
AU2001219672A1 AU2001219672A AU1967201A AU2001219672A1 AU 2001219672 A1 AU2001219672 A1 AU 2001219672A1 AU 2001219672 A AU2001219672 A AU 2001219672A AU 1967201 A AU1967201 A AU 1967201A AU 2001219672 A1 AU2001219672 A1 AU 2001219672A1
Authority
AU
Australia
Prior art keywords
phenoxyethyl
thiourea
hiv
infections
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001219672A
Inventor
Fatih M. Uckun
Taracad K. Venkatachalam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Parker Hughes Institute
Original Assignee
Parker Hughes Institute
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parker Hughes Institute filed Critical Parker Hughes Institute
Publication of AU2001219672A1 publication Critical patent/AU2001219672A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001219672A 2000-10-18 2000-10-18 Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections Abandoned AU2001219672A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2000/041209 WO2002032873A1 (en) 2000-10-18 2000-10-18 Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections

Publications (1)

Publication Number Publication Date
AU2001219672A1 true AU2001219672A1 (en) 2002-04-29

Family

ID=21742152

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001219672A Abandoned AU2001219672A1 (en) 2000-10-18 2000-10-18 Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections

Country Status (2)

Country Link
AU (1) AU2001219672A1 (en)
WO (1) WO2002032873A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593993A (en) * 1991-08-02 1997-01-14 Medivir Ab Method for inhibition of HIV related viruses
US6124324A (en) * 1999-06-23 2000-09-26 Hughes Institute Thiophene-ethyl thiourea compounds and use

Also Published As

Publication number Publication date
WO2002032873A1 (en) 2002-04-25

Similar Documents

Publication Publication Date Title
IL196301A0 (en) Medicament for the treatment of hapatitis c
AU6147401A (en) Compositions and methods for the treatment of cancer
AU2002226069A1 (en) Compositions comprising temozolomide and thalidomide and methods for the treatment of cancer
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
PL370029A1 (en) 2-amino-4-heteroarylaminopyrimidine derivatives for use in the treatment of cancer
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2001283285A1 (en) Antimicrobial composition and methods of use in the treatment of disease
AU2001228703A1 (en) Use of cox-2 inhibitors for the treatment of constipation
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
SI1197485T1 (en) Cyclobuten-dione derivatives for use in the treatment of artherosclerosis
AU2001259507A1 (en) Compounds and methods for the diagnosis and treatment of ehrlichia infection
AU2001275450A1 (en) Bismuth compounds for the treatment and prevention of mucositis
GB0119025D0 (en) Compounds and their therapeutic use
EE200300057A (en) Ingredients for the prevention and treatment of cancer
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001268236A1 (en) Use of aicar and related compounds
AU7402201A (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
AU4432001A (en) Trityl-type compounds and their use
AU2002366195A1 (en) Use of bisindolmaleimide and gemcitabine for the treatment of cancer
AU2001219672A1 (en) Phenoxyethyl-thiourea-pyridine compounds and their use for the treatment of hiv-infections
AU2001281465A1 (en) Treatment of rosacea
AU2000272704A1 (en) Use of compounds for the treatment of obesity